Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease
Joshua Hare Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)…
Read the full articleYou might also wanna read
CircleHub's New Style Lab Turns Fashion Discovery Into a Live, Real-Time Experience for Designers and Models
Manila Times·3h ago
Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline
Manila Times·3h ago
Orion Corporation’s financial reporting and Annual General Meeting in 2027
Manila Times·3h ago
EQT Consortium Raises Tender Offer Price for Kakaku.com to JPY 3,450 Per Share
Manila Times·3h ago
Renk Group AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
Manila Times·4h ago
From the World Cup Stadium to 24/7 Support: How HTX is Redefining VIP Services
Manila Times·4h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.